Biologics Allosource’s Cartilage Allograft Expertise to be Featured at the International Cartilage Regeneration & Joint Preservation Society Annual Meeting byChris StewartApril 5, 2022
Biologics Sports Medicine AlloSource’s ProChondrix CR, Cryopreserved Osteochondral Allograft, To Be Featured At The British Patellofemoral Society Meeting byJosh SandbergJanuary 15, 2021
Sports Medicine AlloSource Announces First Patients Complete 12-Month Milestone In ProChondrix CR Clinical Study For Cartilage Defects In The Knee byChris StewartNovember 17, 2020
Biologics Sports Medicine Research Shows ProChondrix® CR Maintains Consistent, High Cell Viability For Two Years byJosh SandbergOctober 7, 2019
Biologics AlloSource Announces First Patient Enrolled In ProChondrix CR Cartilage Defect Study byJosh SandbergMarch 20, 2019
Biologics AlloSource Announces Two-Year Shelf Life On ProChondrix CR Fresh Cryopreserved Osteochondral Allograft byJosh SandbergMarch 14, 2019
Biologics AlloSource Granted Patent For Proprietary Laser Cutting Enclosure byJosh SandbergNovember 16, 2018
